Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000296080 | SCV000436431 | uncertain significance | Knobloch syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001263255 | SCV001441292 | uncertain significance | Seizure | 2020-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002523187 | SCV003581296 | uncertain significance | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.2947C>T (p.P983S) alteration is located in exon 35 (coding exon 35) of the COL18A1 gene. This alteration results from a C to T substitution at nucleotide position 2947, causing the proline (P) at amino acid position 983 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |